Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.95 USD | +5.42% | -6.45% | +145.63% |
May. 13 | Oppenheimer Adjusts Mind Medicine Price Target to $20 From $29, Maintains Outperform Rating | MT |
May. 08 | Transcript : Mind Medicine Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+145.63% | 610M | |
+28.67% | 49.18B | |
+0.85% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.38% | 26.09B | |
-22.38% | 18.71B | |
+8.00% | 13.26B | |
+32.17% | 12.32B | |
-0.42% | 11.99B |
- Stock Market
- Equities
- MNMD Stock
- News Mind Medicine (MindMed) Inc.
- Transcript : Mind Medicine Inc. - Special Call